January Therapeutics Announces Appointment of Dr. Daniel C. Maneval, PhD as Chief Scientific Officer
January Therapeutics Announces Appointment of Dr. Daniel C. Maneval, PhD as Chief Scientific Officer Share Article As Chief Scientific Officer Dr. Maneval will lead key aspects of the Scientific Team for January’s oncology programs SAN DIEGO (PRWEB) April 27, 2021 January Therapeutics today announced the appointment of Daniel C. Maneval, PhD, as Chief Scientific Officer. Dr. Maneval will lead key aspects of the Scientific Team for January’s oncology programs including the JNTX-101 program (pro-drug albumin-encapsulated ver...
Source: prweb.com